The Genes Influencing Adiponectin Levels Also Influence Risk Factors for Metabolic Syndrome and Type 2 Diabetes

ABSTRACT Results from previous studies suggest that adiponectin levels are associated with risk factors for cardiovascular disease and type 2 diabetes mellitus; however, the genetic and/or environmental components of this relationship have not been characterized. The aims of this study were (1) to assess the presence of pleiotropy between adiponectin levels and risk factors for cardiovascular disease and (2) to study the association of circulating levels of adiponectin with risk factors for cardiovascular disease in the absence and presence of obesity in Mexican American adults from the San Antonio Family Heart Study. Body composition and circulating levels of adiponectin, leptin, and lipid subfractions and measurements of glucose metabolism were measured in 898 subjects. The mean and standard error of the circulating levels of adiponectin was 8.7 ±3.2 μg/ml. Bivariate quantitative analyses between adiponectin levels and phenotypes related to cardiovascular disease and type 2 diabetes mellitus were conducted using the variance decomposition approach implemented in SOLAR. A second analysis in unrelated subjects compared these risk factors between sex and agematched lean and obese subjects with high and low adiponectin levels. We found significant evidence of pleiotropy (i.e., shared genetic effects) between plasma levels of adiponectin and wellestablished risk factors for cardiovascular disease and type 2 diabetes mellitus. Individuals with low adiponectin levels per body weight had more adverse risk profiles. These findings offer new insights into the genetic connection between increasing adiposity and risk for cardiovascular disease and type 2 diabetes mellitus, and they suggest that adiponectin may be an important risk factor for the development of these conditions.

[1]  L. Chuang,et al.  Human genetics of adiponectin in the metabolic syndrome , 2006, Journal of Molecular Medicine.

[2]  S. Cole,et al.  Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  P. A. Tataranni,et al.  A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? , 2005, Diabetes.

[4]  W. Sheu,et al.  Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  Kazunori Shimada,et al.  Adiponectin and atherosclerotic disease. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[6]  S. Cole,et al.  Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons. , 2004, Obesity research.

[7]  Y. Shimada,et al.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease , 2004, Heart.

[8]  P. Havel.  Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. , 2004, Diabetes.

[9]  Cathryn M Lewis,et al.  Meta-Analysis of 4 Coronary Heart Disease Genome-Wide Linkage Studies Confirms a Susceptibility Locus on Chromosome 3q , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  T. Funahashi,et al.  Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. , 2003, Diabetes.

[11]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[12]  J. Bełtowski.  Adiponectin and resistin--new hormones of white adipose tissue. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[13]  C. Stehouwer,et al.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.

[14]  C. Dina,et al.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. , 2001, Human molecular genetics.

[15]  J. Blangero,et al.  The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[17]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[18]  T. Funahashi,et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.

[19]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Dina,et al.  Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.

[22]  R. Ahima,et al.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[23]  NoriyukiOuchi,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[24]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  T Nakamura,et al.  An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[26]  A. Mokdad,et al.  The spread of the obesity epidemic in the United States, 1991-1998. , 1999, JAMA.

[27]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[28]  S. Kihara,et al.  Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. , 1999, Internal medicine.

[29]  S. Coppack,et al.  Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.

[30]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[31]  K. Cianflone.  Acylation stimulating protein and the adipocyte. , 1997, The Journal of endocrinology.

[32]  S. Yamashita,et al.  Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.

[33]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[34]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[35]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[36]  J. Flier,et al.  The adipocyte: Storage depot or node on the energy information superhighway? , 1995, Cell.

[37]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[38]  B. Spiegelman,et al.  Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. , 1993, The Journal of biological chemistry.

[39]  K. Liang,et al.  Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests under Nonstandard Conditions , 1987 .

[40]  J. O’Connell,et al.  Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. , 2005, Diabetes.

[41]  B. Cheatham,et al.  The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. , 2001, Recent progress in hormone research.

[42]  K. Cianflone,et al.  Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. , 1997, Journal of lipid research.

[43]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.